Intellia Therapeutics (NTLA) Stock Price
$11.42 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Intellia Therapeutics, AI stock picks, stock alerts and much more.
NTLA AI Stock Analysis
AI stock analysis for NTLA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Intellia Therapeutics (NTLA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Intellia Therapeutics (NTLA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Intellia Therapeutics (NTLA), currently trading at $11.42, will... Sign up to access price prediction.
About NTLA
-
Intellia Therapeutics, Inc.
-
Symbol
NTLA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.2B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
NTLA Alternative Data
Web Traffic
Intellia Therapeutics receives an estimated 39364 monthly visitors to intelliatx.com, which is up by 8.9% over the last month.
-
Web Traffic
39364
-
Change from Previous Month
8.9%
-
3 Month Change
17.8%
-
YoY Change
17.8%
Twitter Followers
Intellia Therapeutics has 11,723 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
11723
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Instagram Followers
Intellia Therapeutics has 1,283 Instagram Followers on its main Instagram account, down by -0.2% over the last month.
-
Instagram Followers
1283
-
Daily Change
0.2%
-
1 Month Change
0.2%
-
3 Month Change
1.3%
-
YoY Change
1.3%
LinkedIn Followers
63,784 are following Intellia Therapeutics on LinkedIn, up by 1.2% over the last month.
-
LinkedIn Followers
63784
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
3.1%
-
YoY Change
3.1%
Job Postings
Intellia Therapeutics currenly has an estimated 12 open job postings, up by 9.1% over the last month.
-
Job Postings
12
-
Daily Change
0%
-
1 Month Change
9.1%
-
3 Month Change
9.1%
-
YoY Change
9.1%
LinkedIn Employees
According to LinkedIn, Intellia Therapeutics has 443 employees, down by -0.7% over the last month.
-
LinkedIn Employees
443
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
4.7%
-
YoY Change
4.7%
Reddit Mentions
Intellia Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Intellia Therapeutics is 28 out of 100 (bearish), down by -3.4% over the last month.
-
Business Outlook
28
-
Change from Previous Month
3.4%
-
3 Month Change
6.7%
-
YoY Change
6.7%
News Mentions
Intellia Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
NTLA Financials
NTLA Key Metrics
-
Total Revenue
$12.9M
-
Net Income
-$128.9M
-
Earnings per Share
-$1.3
-
Free cash flow
-$86.2M
-
EBITDA
-$133.9M
-
EBITDA Ratio
-10.3993
-
Total Assets
$1.2B
NTLA 2-year Revenue & Income
NTLA 2-year Free Cash Flow
NTLA Technicals
NTLA SMA
NTLA RSI
FAQ
What's the current price of Intellia Therapeutics (NTLA) Stock?
The price of an Intellia Therapeutics (NTLA) share is $11.42.
What's the market cap of Intellia Therapeutics?
The current market cap of Intellia Therapeutics is 1.2B.
What are some stocks similar to Intellia Therapeutics (NTLA) that investors often compare it to?
Intellia Therapeutics (NTLA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Intellia Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Intellia Therapeutics' stock price to be around $11.01 in 2026. Starting from the current price of $11.42, this represents a 3.6% change in price, indicating a neutral outlook for the stock.
How to buy Intellia Therapeutics (NTLA) Stock?
Intellia Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Intellia Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.